Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Postural Orthostatic Tachycardia Syndrome | 4 | 2024 | 54 | 3.390 |
Why?
|
Autonomic Nervous System Diseases | 5 | 2022 | 257 | 2.640 |
Why?
|
Autonomic Nervous System | 5 | 2022 | 671 | 1.680 |
Why?
|
Multiple System Atrophy | 6 | 2022 | 121 | 1.660 |
Why?
|
Orthostatic Intolerance | 3 | 2022 | 20 | 1.550 |
Why?
|
Cerebrovascular Circulation | 12 | 2022 | 2731 | 1.180 |
Why?
|
Tilt-Table Test | 4 | 2021 | 78 | 1.020 |
Why?
|
Mastocytosis | 3 | 2021 | 160 | 1.010 |
Why?
|
Subthalamic Nucleus | 5 | 2011 | 184 | 1.000 |
Why?
|
Parkinson Disease | 9 | 2022 | 2775 | 0.950 |
Why?
|
Penicillanic Acid | 1 | 2024 | 45 | 0.940 |
Why?
|
Head-Down Tilt | 1 | 2023 | 64 | 0.940 |
Why?
|
Syncope, Vasovagal | 1 | 2021 | 38 | 0.790 |
Why?
|
Heart Rate | 7 | 2023 | 4091 | 0.790 |
Why?
|
Primary Dysautonomias | 1 | 2021 | 29 | 0.780 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2021 | 63 | 0.770 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2021 | 105 | 0.760 |
Why?
|
Disaccharides | 1 | 2021 | 171 | 0.750 |
Why?
|
Valsalva Maneuver | 3 | 2021 | 92 | 0.690 |
Why?
|
Sweat Glands | 1 | 2019 | 31 | 0.670 |
Why?
|
Hypocapnia | 1 | 2018 | 34 | 0.660 |
Why?
|
Hypotension, Orthostatic | 1 | 2021 | 255 | 0.630 |
Why?
|
Blood Pressure | 10 | 2023 | 8554 | 0.620 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 98 | 0.590 |
Why?
|
Sweating | 1 | 2017 | 123 | 0.580 |
Why?
|
Skin Physiological Phenomena | 1 | 2017 | 180 | 0.570 |
Why?
|
Deep Brain Stimulation | 5 | 2011 | 748 | 0.570 |
Why?
|
Insulin | 7 | 2023 | 6580 | 0.560 |
Why?
|
Tryptases | 3 | 2021 | 190 | 0.550 |
Why?
|
Galvanic Skin Response | 1 | 2017 | 349 | 0.530 |
Why?
|
Heparin | 1 | 2021 | 1637 | 0.460 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1889 | 0.440 |
Why?
|
Autoantibodies | 1 | 2021 | 2035 | 0.430 |
Why?
|
Administration, Intranasal | 6 | 2022 | 446 | 0.350 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 11725 | 0.340 |
Why?
|
Electrophysiology | 1 | 2011 | 1308 | 0.320 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 652 | 0.310 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 2 | 2019 | 40 | 0.290 |
Why?
|
Dermis | 1 | 2008 | 207 | 0.290 |
Why?
|
Action Potentials | 2 | 2011 | 1806 | 0.290 |
Why?
|
Mast Cells | 3 | 2021 | 1544 | 0.260 |
Why?
|
Reflex | 2 | 2021 | 365 | 0.260 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.260 |
Why?
|
Middle Aged | 40 | 2023 | 213383 | 0.220 |
Why?
|
Hypoglycemic Agents | 5 | 2022 | 2872 | 0.220 |
Why?
|
Humans | 56 | 2024 | 744343 | 0.210 |
Why?
|
Retrospective Studies | 11 | 2024 | 77449 | 0.210 |
Why?
|
Pilot Projects | 3 | 2023 | 8324 | 0.200 |
Why?
|
Biopsy | 3 | 2022 | 6756 | 0.200 |
Why?
|
Monitoring, Intraoperative | 2 | 2009 | 957 | 0.190 |
Why?
|
Female | 39 | 2024 | 380194 | 0.170 |
Why?
|
Male | 39 | 2022 | 350118 | 0.160 |
Why?
|
Cerebral Infarction | 3 | 2010 | 1011 | 0.160 |
Why?
|
Aged | 28 | 2023 | 163280 | 0.160 |
Why?
|
Microelectrodes | 2 | 2011 | 303 | 0.160 |
Why?
|
Hand Strength | 1 | 2021 | 448 | 0.160 |
Why?
|
Syncope | 1 | 2021 | 429 | 0.160 |
Why?
|
Double-Blind Method | 7 | 2023 | 12026 | 0.160 |
Why?
|
Duodenum | 1 | 2021 | 483 | 0.160 |
Why?
|
Neural Conduction | 2 | 2019 | 440 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 570 | 0.150 |
Why?
|
Vasodilation | 2 | 2013 | 944 | 0.150 |
Why?
|
Vasoconstriction | 2 | 2011 | 597 | 0.150 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 850 | 0.150 |
Why?
|
Adult | 19 | 2022 | 214055 | 0.140 |
Why?
|
Posture | 3 | 2010 | 958 | 0.140 |
Why?
|
Functional Laterality | 3 | 2011 | 2290 | 0.130 |
Why?
|
Activities of Daily Living | 4 | 2015 | 2418 | 0.130 |
Why?
|
Brain | 8 | 2022 | 26385 | 0.130 |
Why?
|
Serine | 1 | 2019 | 826 | 0.130 |
Why?
|
Postural Balance | 2 | 2010 | 620 | 0.120 |
Why?
|
Fatigue | 1 | 2022 | 1531 | 0.120 |
Why?
|
Electroencephalography | 2 | 2007 | 6150 | 0.120 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2016 | 243 | 0.120 |
Why?
|
Carbon Dioxide | 1 | 2018 | 1150 | 0.120 |
Why?
|
Anaphylaxis | 1 | 2021 | 746 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1170 | 0.110 |
Why?
|
Memory | 2 | 2020 | 2174 | 0.100 |
Why?
|
Single-Blind Method | 2 | 2016 | 1590 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1736 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2015 | 737 | 0.100 |
Why?
|
Stereotaxic Techniques | 2 | 2009 | 536 | 0.090 |
Why?
|
Atrophy | 2 | 2011 | 1583 | 0.090 |
Why?
|
Huntington Disease | 1 | 2016 | 1124 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2018 | 21746 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 10 | 2014 | 35421 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2011 | 514 | 0.080 |
Why?
|
Stroke | 5 | 2015 | 9981 | 0.080 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.080 |
Why?
|
Disability Evaluation | 2 | 2012 | 1827 | 0.080 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2008 | 200 | 0.080 |
Why?
|
Neurons | 1 | 2007 | 9338 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2009 | 2624 | 0.070 |
Why?
|
Blood Flow Velocity | 5 | 2009 | 1423 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25043 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2703 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 411 | 0.070 |
Why?
|
Electromyography | 1 | 2011 | 1379 | 0.070 |
Why?
|
Genetic Variation | 1 | 2021 | 6544 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 475 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2305 | 0.070 |
Why?
|
Brain Mapping | 2 | 2011 | 6669 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2022 | 57776 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19905 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 605 | 0.060 |
Why?
|
Brain Infarction | 2 | 2003 | 299 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1534 | 0.060 |
Why?
|
Preoperative Care | 2 | 2009 | 2250 | 0.060 |
Why?
|
Prospective Studies | 5 | 2020 | 53288 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9959 | 0.060 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2003 | 56 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.050 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 957 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2005 | 454 | 0.050 |
Why?
|
Cognition | 3 | 2020 | 6770 | 0.050 |
Why?
|
Tachycardia | 1 | 2005 | 619 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4042 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3675 | 0.050 |
Why?
|
Benzazepines | 1 | 2023 | 326 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4364 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 288 | 0.050 |
Why?
|
Disease Progression | 2 | 2015 | 13284 | 0.050 |
Why?
|
Hypertension | 3 | 2008 | 8480 | 0.050 |
Why?
|
Florida | 1 | 2021 | 435 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3778 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.040 |
Why?
|
Anti-Allergic Agents | 1 | 2021 | 141 | 0.040 |
Why?
|
Urticaria | 1 | 2021 | 150 | 0.040 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2019 | 39 | 0.040 |
Why?
|
Ossification, Heterotopic | 1 | 2001 | 239 | 0.040 |
Why?
|
Research Design | 2 | 2020 | 5987 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1041 | 0.040 |
Why?
|
Sphingolipids | 1 | 2019 | 159 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2005 | 832 | 0.040 |
Why?
|
Hemodynamics | 1 | 2007 | 4199 | 0.040 |
Why?
|
alpha-Synuclein | 1 | 2022 | 723 | 0.030 |
Why?
|
Eating | 1 | 2023 | 1536 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 449 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4462 | 0.030 |
Why?
|
Middle Cerebral Artery | 2 | 2008 | 264 | 0.030 |
Why?
|
Image Enhancement | 2 | 2005 | 2921 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2902 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 1442 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1677 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2008 | 292 | 0.030 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2015 | 94 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2015 | 145 | 0.030 |
Why?
|
Brain Ischemia | 2 | 2009 | 3265 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2401 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39050 | 0.030 |
Why?
|
Parkinsonian Disorders | 1 | 2015 | 275 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13989 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 7913 | 0.030 |
Why?
|
Body Mass Index | 1 | 2008 | 12720 | 0.020 |
Why?
|
Acceleration | 1 | 2011 | 181 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3036 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2009 | 15295 | 0.020 |
Why?
|
Animals | 2 | 2022 | 168757 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3420 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2011 | 502 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9313 | 0.020 |
Why?
|
Atlases as Topic | 1 | 2009 | 236 | 0.020 |
Why?
|
Neuronavigation | 1 | 2009 | 167 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9146 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 236 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56430 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6256 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 479 | 0.020 |
Why?
|
Cerebrum | 1 | 2008 | 137 | 0.020 |
Why?
|
Levodopa | 1 | 2007 | 219 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2007 | 184 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 85781 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12745 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2008 | 936 | 0.020 |
Why?
|
Cerebellar Diseases | 1 | 2007 | 226 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3341 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 795 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2009 | 824 | 0.020 |
Why?
|
Organ Size | 1 | 2009 | 2252 | 0.020 |
Why?
|
Sample Size | 1 | 2007 | 845 | 0.020 |
Why?
|
Gait | 1 | 2009 | 793 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.010 |
Why?
|
Hyperventilation | 1 | 2003 | 81 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 2025 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 40561 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2003 | 8863 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
Visual Perception | 1 | 2010 | 1420 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 6993 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1904 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2050 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 2002 | 544 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2002 | 546 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2886 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2009 | 2585 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3508 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
Respiration | 1 | 2005 | 1653 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 2001 | 634 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1286 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2001 | 952 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7785 | 0.010 |
Why?
|
Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
Calcinosis | 1 | 2001 | 1499 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 20129 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8949 | 0.010 |
Why?
|
Contrast Media | 1 | 2005 | 5300 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2002 | 2647 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8340 | 0.010 |
Why?
|
Ultrasonography | 1 | 2001 | 5985 | 0.000 |
Why?
|
United States | 1 | 2015 | 69872 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40075 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 72290 | 0.000 |
Why?
|